发帖
雷达卡
【来源】：锦秋才智
【文件格式】：PDF
【页数】：141
【目录或简介】：
报告目录
2009 年度中国医药研发外包（CRO）市场深度研究及2010 年投资分析报告
·······················································································································10
第一章 医药研发外包（CRO）概述······························································10
第一节 CRO 研究基础···························································································································10
一 CRO 产业定义························································································································· 10
二 CRO 产生背景························································································································· 10
三 CRO 服务范围························································································································· 11
第二节 国内外CRO 市场······················································································································12
一 国际CRO 行业发展················································································································· 12
二 国内CRO 总体发展················································································································· 14
第二章 2008-2009 年全球医药市场背景························································15
第一节 2008 年全球医药市场················································································································15
一 2008 年全球医药并购分析······································································································ 16
二 产业多元化布局······················································································································· 16
三 奥巴马新政立法考验··············································································································· 16
四 医药研发外包权重加大··········································································································· 17
五 2008 年新药审批谨慎·············································································································· 17
六 2008 年仿制药竞争加剧·········································································································· 18
第二节 2008 年全球制药企业················································································································19
一 2008 年全球药品销售规模······································································································ 19
二 2008 年医药巨头经营分析······································································································ 20
三 2008 年医药企业排名·············································································································· 22
四 2008 年医药企业研发投入······································································································
2009年度中国医药研发外包（CRO）市场深度研究及2010年投资分析报告.pdf
(2.55 MB, 需要: 30 个论坛币)
京公网安备 11010802022788号
